ScripThe biopharmaceutical industry cheered Third Harmonic Bio ’s sizeable initial public offering in mid-September but the IPO market in the US has gone quiet since then as broader stock indices – includ
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Doubles Down On Metabolic Disorde